Page 60 - Merck Sharp News Today

A suit was filed on Thursday in the District of New Jersey by plaintiff Merck Sharp & Dohme LLC (Merck) against defendant Gland Pharma Limited

MILAN — Pediatric patients experienced improved psoriasis symptoms and quality of life with ixekizumab treatment, according to a poster presented at the European Academy of Dermatology and Venereology Congress. “About 1% of children and adolescents worldwide are affected by plaque psoriasis (PsO),” Andreas Pinter, MD, medical director of clinical research and senior physician in

Vaxxas is still unlisted, but worth highlighting as yet another Australian success story looks to be unfolding, reports Tim Boreham

Adding talimogene laherparepvec (T-VEC) to pembrolizumab does not improve survival in advanced melanoma, a phase 3 study suggests.

New Delhi, Sep 6 (EFE).- Indian health authorities on Tuesday authorized the emergency use of the first nasal vaccine against Covid-19 developed in India by local lab Bharat Biotech, even as cases have dropped to their lowest in three months. The Drugs Controller General of India has approved the restricted emergency use of Bharat Biotech’s …

Eisai Co., Ltd.

Tris asserted claims of all three patents against Actavis Laboratories FL, Inc. in the U.S. District Court for the District of Delaware.

/PRNewswire/ -- According to Coherent Market Insights, the global osteoarthritis drugs market is estimated to be valued at US$ 8,592.2 million in 2022 and is...

Looking at the state of unemployment across Africa, you find a tapestry weaved from stories of despair. The continent is brimming with young people eager to work, yet jobs are becoming less available.

By Stanley  Achonu  Looking at the state of unemployment across Africa, you find a tapestry weaved with stories of despair. The continent is brimming with young people eager to work, yet jobs are becoming less available. Chances are you likely know someone of ‘job-seeking’ age, hoping to find ‘anything’ to do because ‘things are tough’.  […]